Skip to content Skip to footer
Subscribe Now
PharmaShots Interview In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liquid Biopsy Laboratory Facility
VIEWPOINTS

PharmaShots Interview: In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liquid Biopsy Laboratory Facility

Shots:Brian spoke about opening of its new liquid biopsy lab in Phoenix, AZ and an investment of $45M for the development of its facilitiesBrian also talked about the establishment of lab will enhance company’s molecular profiling capabilities and launch of a blood-based diagnostic assayThe interview gives a view of how Caris Life…
July 4, 2022

Read more

Viewpoints_Dr. David Spetzler
VIEWPOINTS

PharmaShots Interview: Caris Life Sciences’ Dr. Spetzler Shares Insight on AI-Based MI FOLFOXai Predictor

In a recent interview with PharmaShots, Dr. Spetzler, President and Chief Scientific Officer of Caris Life Sciences shared his insights on FOLFOXai and its importance in patients with metastatic colorectal cancer. He also highlights the data supporting the use of FOLFOXai as a predictor of CT efficacy in patients with mCRC.Shots:The validation studies of MI…
July 27, 2021

Read more

Viewpoint_Dr. David_Spetzler_2020
VIEWPOINTS

PharmaShots Interview: Caris Life Sciences’ Dr. Spetzler Shares Insight on AI-Powered Clinico-Genomic Data Platform

In a recent interview with PharmaShots, Dr. Spetzler, President and Chief Scientific Officer of Caris Life Sciences shared his insights and highlights on the launch of CODEai.Shots:CODEai is a real-world clinico-genomic data platform that integrates Caris Life Sciences extensive catalog of molecular data with cancer treatment information and clinical outcomes data for ~215,000…
December 1, 2020

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]